ALB and Hypoalbuminemia: Hypoalbuminemia independently predicts elevated mortality, with Polat et al documenting 1-year mortality rates of 37% versus 12% in patients with albumin levels below versus above 3.10 g/dL.[8] These findings underscore the clinical need for integrated biomarkers that concurrently reflect renal function and inflammatory–nutritional status.